nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—NR3C1—type 2 diabetes mellitus	0.743	1	CbGaD
Amcinonide—ANXA1—nerve—type 2 diabetes mellitus	0.0116	0.197	CbGeAlD
Amcinonide—ANXA1—islet of Langerhans—type 2 diabetes mellitus	0.00561	0.0954	CbGeAlD
Amcinonide—ANXA1—nephron tubule—type 2 diabetes mellitus	0.00452	0.0768	CbGeAlD
Amcinonide—ANXA1—cardiovascular system—type 2 diabetes mellitus	0.00406	0.069	CbGeAlD
Amcinonide—NR3C1—nerve—type 2 diabetes mellitus	0.00402	0.0684	CbGeAlD
Amcinonide—ANXA1—kidney—type 2 diabetes mellitus	0.00397	0.0675	CbGeAlD
Amcinonide—ANXA1—pancreas—type 2 diabetes mellitus	0.00394	0.0671	CbGeAlD
Amcinonide—ANXA1—cortex of kidney—type 2 diabetes mellitus	0.00387	0.0658	CbGeAlD
Amcinonide—ANXA1—adipose tissue—type 2 diabetes mellitus	0.00358	0.0609	CbGeAlD
Amcinonide—ANXA1—liver—type 2 diabetes mellitus	0.00251	0.0427	CbGeAlD
Amcinonide—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.00195	0.0331	CbGeAlD
Amcinonide—NR3C1—nephron tubule—type 2 diabetes mellitus	0.00157	0.0267	CbGeAlD
Amcinonide—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.00141	0.024	CbGeAlD
Amcinonide—NR3C1—kidney—type 2 diabetes mellitus	0.00138	0.0235	CbGeAlD
Amcinonide—NR3C1—pancreas—type 2 diabetes mellitus	0.00137	0.0233	CbGeAlD
Amcinonide—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.00134	0.0228	CbGeAlD
Amcinonide—NR3C1—adipose tissue—type 2 diabetes mellitus	0.00124	0.0211	CbGeAlD
Amcinonide—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00113	0.105	CrCbGaD
Amcinonide—NR3C1—liver—type 2 diabetes mellitus	0.000872	0.0148	CbGeAlD
Amcinonide—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000349	0.0323	CrCbGaD
Amcinonide—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000339	0.0313	CrCbGaD
Amcinonide—Diflorasone—NR3C1—type 2 diabetes mellitus	0.00032	0.0296	CrCbGaD
Amcinonide—Desonide—NR3C1—type 2 diabetes mellitus	0.00032	0.0296	CrCbGaD
Amcinonide—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000313	0.0289	CrCbGaD
Amcinonide—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000309	0.0286	CrCbGaD
Amcinonide—Fludrocortisone—AR—type 2 diabetes mellitus	0.000304	0.0282	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000294	0.00157	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.00029	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000289	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.000287	0.00154	CbGpPWpGaD
Amcinonide—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000287	0.0265	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000284	0.00152	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000281	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000279	0.00149	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000278	0.00149	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000275	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	0.000275	0.00147	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000274	0.00146	CbGpPWpGaD
Amcinonide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000274	0.0253	CrCbGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000273	0.00146	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000272	0.00146	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000272	0.00145	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000271	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000271	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	0.000269	0.00144	CbGpPWpGaD
Amcinonide—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000269	0.0249	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000269	0.00144	CbGpPWpGaD
Amcinonide—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000265	0.0245	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000261	0.0014	CbGpPWpGaD
Amcinonide—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000261	0.0241	CrCbGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000259	0.00139	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000258	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.000257	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—type 2 diabetes mellitus	0.000256	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000253	0.00136	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000253	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000253	0.00135	CbGpPWpGaD
Amcinonide—Fluoxymesterone—AR—type 2 diabetes mellitus	0.000251	0.0233	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000251	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000251	0.00134	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.00025	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000246	0.00132	CbGpPWpGaD
Amcinonide—Budesonide—NR3C1—type 2 diabetes mellitus	0.000246	0.0228	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000246	0.00132	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000246	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000246	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000244	0.00131	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000242	0.0013	CbGpPWpGaD
Amcinonide—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000241	0.0223	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.00024	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.00024	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000238	0.00127	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000236	0.00126	CbGpPWpGaD
Amcinonide—Mometasone—NR3C1—type 2 diabetes mellitus	0.000234	0.0216	CrCbGaD
Amcinonide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000231	0.0214	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000224	0.0012	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000224	0.0012	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000223	0.00119	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000223	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000221	0.00118	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.00022	0.00118	CbGpPWpGaD
Amcinonide—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000218	0.0202	CrCbGaD
Amcinonide—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000218	0.0202	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000218	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000217	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000214	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000213	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000213	0.00114	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000212	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000212	0.00114	CbGpPWpGaD
Amcinonide—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000212	0.0196	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000209	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000208	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000207	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—type 2 diabetes mellitus	0.000207	0.00111	CbGpPWpGaD
Amcinonide—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000206	0.0191	CrCbGaD
Amcinonide—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000206	0.0191	CrCbGaD
Amcinonide—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000206	0.0191	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000206	0.0011	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000203	0.00109	CbGpPWpGaD
Amcinonide—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000201	0.0185	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.0002	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.0002	0.00107	CbGpPWpGaD
Amcinonide—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000199	0.0184	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000197	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000197	0.00106	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000196	0.00105	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000195	0.00104	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000195	0.00104	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000193	0.00103	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000193	0.00103	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000192	0.00102	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000188	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000187	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000187	0.000999	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000186	0.000997	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000186	0.000993	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000184	0.0171	CrCbGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000184	0.000985	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000184	0.000982	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000184	0.000982	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000183	0.000979	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000183	0.000976	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000182	0.000976	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000182	0.000971	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000181	0.000968	CbGpPWpGaD
Amcinonide—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000181	0.0167	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000179	0.00096	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000179	0.000959	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000177	0.000944	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000176	0.000939	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000174	0.000933	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000174	0.000932	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000174	0.000931	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.000171	0.000913	CbGpPWpGaD
Amcinonide—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	0.000171	0.0158	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000169	0.000905	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000167	0.000893	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000167	0.000891	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000166	0.000889	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	0.000166	0.000888	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000166	0.000886	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	0.000166	0.000886	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	0.000165	0.000885	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	0.000165	0.000884	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000165	0.000882	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000163	0.000874	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000163	0.000871	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000163	0.000869	CbGpPWpGaD
Amcinonide—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000162	0.015	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	0.000162	0.000867	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	0.00016	0.000855	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.00016	0.000853	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000157	0.000838	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000155	0.00083	CbGpPWpGaD
Amcinonide—Dexamethasone—NOS2—type 2 diabetes mellitus	0.000153	0.0141	CrCbGaD
Amcinonide—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	0.000151	0.014	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000151	0.000807	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000149	0.000799	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000148	0.000794	CbGpPWpGaD
Amcinonide—Prednisone—NR3C1—type 2 diabetes mellitus	0.000147	0.0136	CrCbGaD
Amcinonide—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	0.000145	0.0134	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	0.000145	0.000773	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000144	0.000772	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000144	0.000767	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000143	0.000766	CbGpPWpGaD
Amcinonide—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000143	0.0132	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000141	0.000755	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	0.000141	0.000755	CbGpPWpGaD
Amcinonide—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	0.00014	0.0129	CrCbGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	0.000139	0.000745	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	0.000138	0.000741	CbGpPWpGaD
Amcinonide—Prednisolone—NR3C1—type 2 diabetes mellitus	0.000136	0.0125	CrCbGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	0.000135	0.000721	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000134	0.000719	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	0.000134	0.000716	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000133	0.000712	CbGpPWpGaD
Amcinonide—Betamethasone—NR3C1—type 2 diabetes mellitus	0.000133	0.0123	CrCbGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	0.000133	0.00071	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000132	0.000706	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000132	0.000706	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	0.000132	0.000705	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.00013	0.000695	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.00013	0.000694	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000129	0.000688	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000129	0.000688	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000128	0.000686	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000128	0.000686	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000128	0.000685	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000128	0.000683	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	0.000127	0.00068	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000127	0.000677	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000122	0.000653	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.00012	0.000642	CbGpPWpGaD
Amcinonide—Flunisolide—CYP3A4—type 2 diabetes mellitus	0.00012	0.0111	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000119	0.000635	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000117	0.000628	CbGpPWpGaD
Amcinonide—Ciclesonide—CYP3A4—type 2 diabetes mellitus	0.000116	0.0108	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000116	0.00062	CbGpPWpGaD
Amcinonide—Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.000115	0.0107	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000115	0.000613	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000114	0.000609	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000113	0.000605	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000112	0.000596	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000111	0.000595	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000111	0.000594	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000111	0.000591	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000109	0.000583	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000107	0.00057	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000106	0.000566	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000103	0.000551	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000103	0.00055	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000103	0.00055	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000102	0.000545	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCC2—type 2 diabetes mellitus	0.000101	0.00937	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000101	0.000542	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.0001	0.000535	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.96e-05	0.000533	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.96e-05	0.000532	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	9.93e-05	0.000531	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.79e-05	0.000523	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.75e-05	0.000521	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.75e-05	0.000521	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.63e-05	0.000515	CbGpPWpGaD
Amcinonide—Triamcinolone—CYP3A4—type 2 diabetes mellitus	9.4e-05	0.0087	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.36e-05	0.0005	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—type 2 diabetes mellitus	9.21e-05	0.00851	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.07e-05	0.000485	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.02e-05	0.000483	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GCG—type 2 diabetes mellitus	8.91e-05	0.000477	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.91e-05	0.000477	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	8.91e-05	0.000477	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	8.82e-05	0.000472	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.77e-05	0.000469	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	8.75e-05	0.000468	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.74e-05	0.000467	CbGpPWpGaD
Amcinonide—Prednisone—CYP3A4—type 2 diabetes mellitus	8.53e-05	0.00789	CrCbGaD
Amcinonide—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	8.41e-05	0.00777	CrCbGaD
Amcinonide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	8.39e-05	0.000449	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.34e-05	0.000446	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	8.33e-05	0.000446	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	8.23e-05	0.00044	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.19e-05	0.000438	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.19e-05	0.000438	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	8.15e-05	0.000436	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	8.07e-05	0.000432	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	8.03e-05	0.000429	CbGpPWpGaD
Amcinonide—Prednisolone—CYP3A4—type 2 diabetes mellitus	7.86e-05	0.00727	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.75e-05	0.000415	CbGpPWpGaD
Amcinonide—Dexamethasone—NR3C1—type 2 diabetes mellitus	7.73e-05	0.00715	CrCbGaD
Amcinonide—Betamethasone—CYP3A4—type 2 diabetes mellitus	7.7e-05	0.00712	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.68e-05	0.000411	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	7.58e-05	0.000406	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.58e-05	0.000405	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.58e-05	0.000405	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	7.56e-05	0.000404	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.55e-05	0.000403	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—type 2 diabetes mellitus	7.54e-05	0.00697	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.51e-05	0.000402	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	7.5e-05	0.000401	CbGpPWpGaD
Amcinonide—Prednisone—ALB—type 2 diabetes mellitus	7.44e-05	0.00688	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.44e-05	0.000398	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.32e-05	0.000392	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.3e-05	0.00039	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.21e-05	0.000385	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2E1—type 2 diabetes mellitus	7.11e-05	0.00658	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.99e-05	0.000374	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.85e-05	0.000366	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.56e-05	0.000351	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	6.48e-05	0.000347	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.44e-05	0.000345	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—C3—type 2 diabetes mellitus	6.3e-05	0.000337	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	6.24e-05	0.000334	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	6.05e-05	0.000324	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.01e-05	0.000321	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.99e-05	0.00032	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.98e-05	0.00032	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.88e-05	0.000315	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.86e-05	0.000314	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.86e-05	0.000314	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.8e-05	0.00031	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	5.72e-05	0.000306	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.53e-05	0.000296	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.23e-05	0.00028	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	5.23e-05	0.00028	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	5.16e-05	0.000276	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INS—type 2 diabetes mellitus	5.01e-05	0.000268	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	5e-05	0.000267	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	5e-05	0.000267	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.93e-05	0.000264	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	4.9e-05	0.000262	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.84e-05	0.000259	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.84e-05	0.000259	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.82e-05	0.000258	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	4.64e-05	0.000248	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.6e-05	0.000246	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP3A4—type 2 diabetes mellitus	4.48e-05	0.00414	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.39e-05	0.000235	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.39e-05	0.000235	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—type 2 diabetes mellitus	4.39e-05	0.00406	CrCbGaD
Amcinonide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	4.25e-05	0.000227	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.13e-05	0.000221	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	3.96e-05	0.000212	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.76e-05	0.000201	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.73e-05	0.000199	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.7e-05	0.000198	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.65e-05	0.000195	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	3.61e-05	0.000193	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.52e-05	0.000188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.49e-05	0.000186	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.42e-05	0.000183	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.25e-05	0.000174	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.19e-05	0.000171	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.16e-05	0.000169	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	3e-05	0.000161	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.9e-05	0.000155	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.85e-05	0.000152	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	2.48e-05	0.000133	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.24e-05	0.00012	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.19e-05	0.000117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.02e-05	0.000108	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	9.81e-06	5.25e-05	CbGpPWpGaD
